SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

SERINO, Maria Luisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.399
AS - Asia 4.457
EU - Europa 2.979
SA - Sud America 734
AF - Africa 112
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 9
Totale 15.699
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.212
SG - Singapore 1.746
CN - Cina 1.081
IT - Italia 897
BR - Brasile 580
VN - Vietnam 506
DE - Germania 457
UA - Ucraina 364
HK - Hong Kong 328
TR - Turchia 282
GB - Regno Unito 242
PL - Polonia 218
FI - Finlandia 185
FR - Francia 141
JP - Giappone 120
SE - Svezia 115
RU - Federazione Russa 92
CA - Canada 89
IN - India 87
MX - Messico 78
AR - Argentina 61
ID - Indonesia 56
NL - Olanda 49
SM - San Marino 49
BD - Bangladesh 48
ZA - Sudafrica 46
ES - Italia 40
EC - Ecuador 31
IQ - Iraq 29
BE - Belgio 26
PK - Pakistan 25
CZ - Repubblica Ceca 23
VE - Venezuela 21
LT - Lituania 19
MA - Marocco 14
AT - Austria 13
EG - Egitto 13
CO - Colombia 12
UZ - Uzbekistan 12
LK - Sri Lanka 11
SA - Arabia Saudita 11
PY - Paraguay 10
AE - Emirati Arabi Uniti 9
CL - Cile 9
IR - Iran 9
KE - Kenya 9
MY - Malesia 9
PH - Filippine 9
IE - Irlanda 8
AU - Australia 7
AZ - Azerbaigian 7
IL - Israele 7
KZ - Kazakistan 7
NP - Nepal 7
TH - Thailandia 7
DO - Repubblica Dominicana 6
JO - Giordania 6
TN - Tunisia 6
AL - Albania 5
BG - Bulgaria 5
DK - Danimarca 5
GR - Grecia 5
KR - Corea 5
PS - Palestinian Territory 5
SN - Senegal 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CH - Svizzera 4
CR - Costa Rica 4
DZ - Algeria 4
EU - Europa 4
JM - Giamaica 4
NO - Norvegia 4
PE - Perù 4
RO - Romania 4
BH - Bahrain 3
BO - Bolivia 3
ET - Etiopia 3
HN - Honduras 3
HR - Croazia 3
KG - Kirghizistan 3
LB - Libano 3
NG - Nigeria 3
OM - Oman 3
TW - Taiwan 3
UY - Uruguay 3
BF - Burkina Faso 2
CG - Congo 2
GE - Georgia 2
KW - Kuwait 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
AO - Angola 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
GD - Grenada 1
HU - Ungheria 1
KH - Cambogia 1
Totale 15.688
Salva come PNG Salva come JPEG
Città #
Singapore 1.018
Ashburn 797
Woodbridge 658
Fairfield 536
Chandler 484
Jacksonville 408
San Jose 385
Beijing 378
Santa Clara 347
Hong Kong 324
Houston 300
Ann Arbor 261
Seattle 238
Wilmington 224
Warsaw 212
Cambridge 157
Ho Chi Minh City 151
Izmir 151
New York 140
Ferrara 132
Los Angeles 131
Munich 128
Tokyo 118
Hanoi 115
Nanjing 112
Milan 104
Dallas 103
Princeton 86
Lauterbourg 81
Boardman 72
Helsinki 66
Orem 65
Shanghai 60
Council Bluffs 51
Mexico City 50
São Paulo 50
San Diego 47
London 44
The Dalles 42
Turku 41
Buffalo 39
Bremen 38
Chicago 35
Jakarta 35
Shenyang 34
Montreal 33
Dearborn 32
Chennai 31
Rome 31
Hebei 30
Johannesburg 29
Toronto 29
Denver 26
Frankfurt am Main 26
Nanchang 26
Phoenix 26
Brooklyn 25
Rio de Janeiro 25
Brussels 24
Da Nang 24
Haiphong 24
Changsha 23
Amsterdam 22
Boston 22
Jiaxing 20
Redwood City 20
Düsseldorf 19
Stockholm 19
Tianjin 18
Manchester 17
Atlanta 16
Naples 16
Nuremberg 16
Curitiba 15
Hefei 15
Hải Dương 15
Jinan 15
Mountain View 15
Poplar 15
Bologna 14
Moscow 14
Brasília 13
Brno 13
Falls Church 13
Guangzhou 13
Baghdad 12
Des Moines 12
Dong Ket 12
Washington 12
Bắc Ninh 11
Charlotte 11
Domagnano 11
Guayaquil 11
Meda 11
Tashkent 11
Colombo 10
Jackson 10
Kunming 10
San Francisco 10
Ankara 9
Totale 10.050
Salva come PNG Salva come JPEG
Nome #
ProC Global test>ProC Complete test: una modificazione del Global test per la misurazione contemporanea della attività della PC, della PS, e del fenotipo Leiden. 582
Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in Cognitive Impairment Diseases 283
Inherited genetic predispositions in F13A1 and F13B genes predict abdominal adhesion formation: identification of gender prognostic indicators 283
Ricerche metodologiche sul dosaggio del cofattore Ristocetinico per la diagnosi di morbo di von Willebrand. 277
Effect of factor XIII-A G185T polymorphism on visual prognosis after photodynamic therapy for neovascular macular degeneration 266
The active metabolite of warfarin (3′-hydroxywarfarin) and correlation with INR, warfarin and drug weekly dosage in patients under oral anticoagulant therapy: A pharmacogenetics study 260
Coagulation factor XIIIA (F13A1): Novel perspectives in treatment and pharmacogenetics 258
COVID-19 and individual genetic susceptibility/receptivity: Role of ACE1/ACE2 genes, immunity, inflammation and coagulation. might the double x-chromosome in females be protective against SARS-COV-2 compared to the single x-chromosome in males? 246
Factor XIII V34L polymorphism modulates the risk of chronic venous leg ulcer progression and extension 244
A novel mutation (Leu817Pro) causing type 2A von Willebrand disease 244
Factor XIII contrasts the effects of metalloproteinases in human dermal fibroblast cultured cells 242
F13A1 gene variant (V34L) and residual circulating FXIIIA levels predict short-and long-term mortality in acute myocardial infarction after coronary angioplasty 239
Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report. 236
A common mutation in the gene for coagulation factor XIII-A (Val34Leu): A risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases 235
Assessment of the interlaboratory variability and robustness of JAK2V617F mutation assays: A study involving a consortium of 19 Italian laboratories 234
Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker? 233
Coexistence of antithrombin deficiency, factor V Leiden and hyperhomocysteinemia in a thrombotic family. 230
Blood Group O Protects against Inhibitor Development in Severe Hemophilia A Patients 216
A photometric assay for factor-XIII in chronic hepatopathies. 215
C677T/A1298C MTHFR Gene Mutations, Homocysteine, Folate Levels and MTHFR Activity, in Normal Subjects and Cases with Myocardial Infarction 215
Coexistence of factor V G1691A and factor II G20210A gene mutations in a thrombotic family is associated with recurrence and early onset of venous thrombosis 212
Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults 211
A modified functional Global test to measure protein C, protein S activities and the activated protein C-resistance phenotype. 208
FXIII levels and genotypes in myocardial infarction: a potential novel prognostic biomarker? 205
A photometric method for the dosage of factor XIII applied to the study of chronic hepatopathies. 197
C677T Substitution in the Methylenetetrahydrofolate Reductase Gene as a Risk Factor for Venous Thrombosis and Arterial Disease in Selected Patients. 187
An Italian Family with a Novel Mutation Causing Type 2A von Willebrand Disease and with Reduced Levels of von Willebrand Factor not Linked with the von Willebrand Factor Gene. 185
Center-Related Determinants of VKA Anticoagulation Quality: A Prospective, Multicenter Evaluation 183
A de novo antithrombin mutation found in a patient with deep vein thrombosis and vascular abnormalities 182
Dihydrofolate reductase (DHFR) 19-bp ins/del polymorphism and methylenetetrahydrofolate reductase (MTHFR) C677T in coronary heart disease patients: potential intracellular folate unbalancing. 178
Deletion of exons 26-34 (domain D3-A3) of von Willebrand-factor gene in the von Willebrand disease type-II. 177
Cancers in patients with hemophilia: a retrospective study from the Italian Association of Hemophilia Centers 177
The reduced sensitivity of the ProC (R) Global test in protein S deficient subjects reflects a reduction in the associated thrombotic risk 176
Cis-segregation of c.1171c>t stop codon (p.r391*) in serpinc1 gene and c.1691g>a transition (p.r506q) in f5 gene and selected gwas multilocus approach in inherited thrombophilia 176
Factor XIIIA V34L and Factor XIIIB H95R Gene Polymorphisms: Effects on the Risk of Myocardial Infarction and on Survival. 175
A modified functional global test to measure PC, PS activities and the APC-resistance phenotype 172
Common Polymorphisms in the Metabolic Folate Pathway Decrease the Risk of Acute Lymphocitic Leukemia in Adults 171
Common Gene Polymorphisms in the Metabolic Folate and Methylation Pathway and the Risk of Acute Lymphoblastic Leukemia and non-Hodgkin’s Lymphoma 170
A web-based clinical record 'xl'Emofilia® 'for outpatients with haemophilia and allied disorders in the region of Emilia-Romagna: Features and pilot use 170
Different anticoagulant response to activated protein C (APC test) and to Agkistrodon Contortix venom (ACV test) in a family with FV-R506Q substitution 169
Common Polymorphisms in the Metabolic Folate Pathway Decrease the Risk of Acute Lymphocytic Leukemia in Adults 169
Factor XIII-A Gene Mutation (Val34Leu) and Arterial Vascular Disease 168
Clinical observations on the relationship between idiopathic thrombocytopenic purpura lupus anticoagulant and anticardio-lipin antibody syndrome. 167
Factor XIIIA-V34L and Factor XIIIB-H95R Gene Variants and Survival after Myocardial Infarction. 163
Maternal Haplotypes in DHFR Promoter and MTHFR Gene in Tuning Childhood Acute Lymphoblastic Leukemia Onset-Latency: Genetic/Epigenetic Mother/Child Dyad Study (GEMCDS) 163
Therapeutic management and costs of severe haemophilia A patients with inhibitors in Italy 162
Una "rete" per proteggere il cuore. (FAR 2013) 162
Effect of factor XIII Val34Leu polymorphism on plasma clot formation: crosslinking functions and clot longevity properties. 160
FXIII Levels in Myocardial Infarction: a Potential Novel Prognostic Biomarker? 157
Malattie emorragiche vascolari. 156
Spectrum of F8 gene mutations in haemophilia A patients from a region of Italy: Identification of 23 new mutations 155
Low folate levels and thermolabile methylenetetrahydrofolate reductase as primary determinant of mild hyperhomocystinemia in normal and thromboembolic subjects 155
Caratterizzazione di una nuova mutazione nell’esone 28 del gene del fattore di von Willebrand (FvW) responsabile della malattia di vW di tipo IIA. 154
Mortality and causes of death in Italian persons with haemophilia, 1990-2007 152
Coexistence of antitrhombin deficency, factor V Leiden and hereditary hyperhomocyst(e)inemia in a thrombotic family. 151
The G to T Point Mutation (Val34Leu) in the Factor XIII-A Subunit Gene in Venous Leg Ulcers 148
A Common mutation in the gene for coagulation factor XIII-A (V34L): a risk factor for hemorrhagic disorders it is protective against atherothrombotic diseases. 147
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients. 145
Resistance to activated protein C and low levels of protein S activity in nine thrombophilic families: a correct diagnosis. 143
Anticardiolipin antibody-related thrombocytopenia: persistent remission after splenectomy. 142
Epigenetic role of LINE-1 methylation and key genes in pregnancy maintenance 141
Low folate levels and thermolabile MTHFR as primary determinant of mild Hyperhomocysteinemia in normal and thromboembolic subjects. 141
Factor V Levels in a Cohort of Patients Eligible for Oral Anticoagulant Therapy. 138
Differente risposta alla Proteina C attivata della muatazione R506Q del fattore V della coagulazione (FV Leiden) in due generazioni della stessa famiglia. 135
MTHFR C677T/A1298C, MS A2756G and MTRR A66G Gene Polymorphisms: Effects on Homocysteine Levels and Risk of Miocardial Infarction 134
Thrombotic risk in thalassemic patients 134
Host genetics impact on SARS-CoV-2 vaccine-induced immunoglobulin levels and dynamics: The role of TP53, ABO, APOE, ACE2, HLA-A, and CRP genes 132
Low Sensitivity to Endogenous Activated Protein C in Protein S Deficient Subjects Reflects a Reduction in the Thrombotic Risk 129
Bassi livelli di Proteina S e Resistenza alla Proteina C attivata in dieci famiglie italiane. 127
F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypes 127
High protein C plasma levels affect the response to exogenous preactivated protein C and enhance that to endogenous Protac-mediated activated protein C. 121
Favourable recombinant factor IX pharmacokinetics outcomes in severe hemophilia B patients with FIX activation site mutations 119
DHFR 19-bp insertion/deletion polymorphism and MTHFR C677T in adult acute lymphoblastic leukaemia: is the risk reduction due to intracellular folate unbalancing? 119
Gene Dosage of F5 c.3481C>T Stop-Codon (p.R1161Ter) Switches the Clinical Phenotype from Severe Thrombosis to Recurrent Haemorrhage: Novel Hypotheses for Readthrough Strategy 118
null 118
Determinazione dell’anticoagulante lupico (LAC) con un metodo al caolino automatizzato. 114
MTHFR Specific Activity, Homocysteine and Folate Levels in Subjects with Thermolabile MTHFR (C677T) 111
Genotype and PK Hemophilia B International Study (GePKHIS) - A progress Report 108
null 102
Different anticoagulant response to activated protein C (APC-test) and to Agkistrodon Contortix Venom (ACV-test) in a family with FV-R506Q substitution 100
FXIII-A V34L and FXIII-B H95R gene polymorphism: effects on the efficacy of thrombolytic therapy in acute myocardial infarction. 99
Detection of a Protein C Gene Mutation Present in the Asymptomatic and not in the Thrombosis-Prone Lineage. 93
miRNAs Epigenetic Tuning of Wall Remodeling in the Early Phase after Myocardial Infarction: A Novel Epidrug Approach 93
null 91
Common Factor XIII Gene Polymorphisms In Venous Leg Ulcers. 87
Treatment outcome and postoperative complications of mucogingival surgery in a case of type I von Willebrand disease 87
Piastrinopenia da anticorpi anticardiolipina: remissione persistente dopo splenectomia. 85
Conteggio piastrinico e terapia sostitutiva in un paziente con Malattia di von Willebrand tipo 2B. 85
null 85
null 80
Sui rapporti tra anticorpi anticardiolipina e ß-2-glicoproteina I plasmatica. 78
Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey. 72
In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency 68
GRB 130427A: a Nearby Ordinary Monster 64
Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy. 63
null 61
null 49
Totale 15.846
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.115
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 556
Totale 63.671
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021392 0 0 0 0 0 0 0 0 0 181 151 60
2021/2022837 30 77 46 41 65 36 37 51 28 86 104 236
2022/20231.093 106 104 21 131 189 156 60 109 111 9 63 34
2023/2024605 53 69 26 26 72 94 28 49 9 21 25 133
2024/20252.456 72 45 175 91 312 188 97 122 467 256 353 278
2025/20265.872 633 262 536 882 945 445 684 340 592 553 0 0
Totale 15.846